Hatsuki Miyata Net Worth

What's Hatsuki Miyata's mailing address?

Hatsuki's mailing address filed with the SEC is C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE, NJ, 07645.

Insiders trading at Balchem

Over the last 22 years, insiders at Balchem have traded over $37,143,279 worth of Balchem stock and bought 47,350 units worth $1,702,145 . The most active insiders traders include Dino A Rossi, Frank Fitzpatrick, and David F Ludwig. On average, Balchem executives and independent directors trade stock every 36 days with the average trade being worth of $2,396,094. The most recent stock trade was executed by Gunsteren Job Leonard Van on 31 July 2024, trading 7,750 units of BCPC stock currently worth $462,288.

What does Balchem do?

founded in 1967, balchem provides state-of-the-art solutions and the finest quality products for a range of industries worldwide. our company consists of four business segments: human nutrition & health; specialty products; animal nutrition and health and industrial products. balchem employs approximately 1,000 people worldwide who are engaged in many diverse activities, developing our company into chosen market leadership positions. visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!

Balchem executives and stock owners

Balchem executives and other stock owners filed with the SEC include:

• Theodore Harris,
  Chairman of the Board, President, Chief Executive Officer
• Theodore L. Harris,
  Chairman, CEO & Pres
• Martin Bengtsson,
  Chief Financial Officer
• Scott Mason,
  Vice President of Manufacturing and Supply Chain and Vice President and General Manager, Industrial Products
• William Backus,
  Chief Accounting Officer
• Mark Stach,
  General Counsel, Secretary
• Carl Martin Bengtsson,
  CFO & Treasurer
• James C. Hyde,
  Sr. VP and GM of Human Nutrition & Health
• Mark A. Stach,
  Gen. Counsel & Corp. Sec.
• John Televantos,
  Lead Independent Director
• Daniel Knutson,
  Independent Director
• Matthew Wineinger,
  Independent Director
• Perry Premdas,
  Independent Director
• David Fischer,
  Independent Director
• Paul Coombs,
  Independent Director
• Joyce Lee,
  Independent Director
• Dino A Rossi,
  President and CEO
• Edward Mcmillan,
  Director
• Matthew David Houston,
  General Counsel, Secretary
• Frank Fitzpatrick,
  Corp Controller & Treasurer
• Mary Theresa Coelho,
  Chief Financial Officer
• Monica Vicente,
  
• Olivier Rigaud,
  
• Elaine R Wedral,
  Director
• Richard Allen Bendure,
  Chief Operating Officer
• Francis X Mcdermott,
  Director
• Paul H Richardson,
  VP Research and Development
• Dana E. Putnam,
  VP and General Manager
• Cruce Patricia Siuta,
  Vice President Technology
• Israel Sheinberg,
  Director
• Winston A Samuels,
  Vice President/GM Encapsulates
• Hoyt Jr Ammidon,
  Director
• Kenneth P Mitchell,
  Director
• Robert T Miniger,
  VP/Human Resources
• David F Ludwig,
  Vice President
• James C Hyde,
  Sr. Vice President
• Kathleen B Fish,
  
• Frederic Boned,
  SVP/GM, Human Nutri. & Health
• Martin Luther Reid,
  SVP Chief Supply Chain Officer
• Hatsuki Miyata,
  EVP, Gen. Counsel & Secretary
• Gunsteren Job Leonard Van,
  SVP and GM, Specialty Products
• Michael Robert Sestrick,
  SVP & Chief Technology Officer
• Michael Brent Tignor,
  SVP & Chief HR Officer
• Jonathan Harrison Griffin,
  SVP & GM, Animal Nutrition